This is the problem leadership must make legible before adding more pipeline, tooling, headcount, or implementation burden.
The organization is surrounded by AI point solutions, but the work still lives across payer rules, portals, EHR data, CRM, RCM queues, documentation, humans, and exceptions. Without a design layer, automation can create more fragmentation.
What gets built
A working management system, not a recommendation left in a deck.
The scope is organized around the artifacts, operating rules, and decision cadence the team needs to keep using after the engagement.
01
Solution architecture across signal intake, context assembly, agentic work blocks, human review, system action, and proof loops.
02
RCM and denial-prevention design patterns for eligibility, documentation, coding review, authorization packets, appeals, and underpayment triage.
03
Prior authorization orchestration model for APIs, portals, payer rules, evidence packets, status monitoring, and escalation.
04
Governance model that defines where AI can recommend, draft, route, monitor, or score, and where human approval is required.
05
Measurement spine for cycle time, clean-claim rate, denial prevention, appeal yield, A/R days, access speed, and staff capacity.
Proof patterns
What leadership should be able to observe.
01
Claims and referral leakage surfaced through claims forensics.
02
AI-assisted RevOps patterns across lifecycle architecture, scoring, attribution, and revenue-quality reporting.
03
Payer/VBC and provider-network operating fluency across reimbursement, workflow, access, and value proof.
Decision questions
What the executive room must answer.
01
Which revenue-cycle or access workflow is costly enough and bounded enough to design first?
02
What evidence sources, rules, exceptions, and approvals must be assembled before action?
03
Where can AI safely draft, score, route, or monitor without replacing human judgment?
04
Which proof metric would make the CFO, COO, or founder believe the system is working?
Trust boundary
What this mandate will not pretend away.
Do not start with a model demo before mapping work ownership and evidence sources.
Do not let agents make autonomous clinical, referral, payer, or patient-impact decisions without human review.
Do not measure AI value in prompts, documents generated, or dashboard views alone.
Related proof
Cases with the evidence boundary left visible.
These records are contextual proof paths, not blanket client-outcome claims. Evidence class and claim boundary are shown from the public case record where available.